Gainers

  • TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.

read more

Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Abcam Charts.
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Abcam Charts.